Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | BBO-11818 |
Synonyms | |
Therapy Description |
BBO-11818 is a selective KRAS inhibitor with activity KRAS variants including G12D and G12V, potentially leading to decreased tumor cell proliferation and reduced tumor growth (Cancer Res (2025) 85 (8_Supplement_1): 4378). |